quinazolines has been researched along with eye in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, SE; Trew, DR; Wright, LA | 1 |
| Kawakami, S; Kawazu, K; Kitahara, T; Nakamura, J; Nakashima, M; Nishida, K; Sakanaka, K; Sasaki, H; Tomonari, M | 1 |
| Ben-Porat, L; Heelan, RT; Heinemann, MH; Kris, MG; Miller, VA; Pao, W; Pizzo, BM; Sachs, DL; Shah, NT; Tyson, LB | 1 |
| Araie, M; Hara, H; Ichikawa, M; Oku, H; Shimazawa, M | 1 |
| Aritakula, A; Ramasamy, A | 1 |
| Jeibmann, A; Klämbt, C; Paulus, W; Witte, HT | 1 |
| Acosta, MC; Callejo, G; Castany, M; Castellanos, A; Gallar, J; Gasull, X; Giblin, JP; Gual, A; Luna, C | 1 |
1 review(s) available for quinazolines and eye
| Article | Year |
|---|---|
Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Eye; Glaucoma; Humans; Neurons; Optic Nerve; Quinazolines; Receptors, Adrenergic, alpha-1; Retina; Retinal Vessels | 2005 |
1 trial(s) available for quinazolines and eye
| Article | Year |
|---|---|
Ocular responses in healthy subjects to topical bunazosin 0.3%--an alpha 1-adrenoceptor antagonist.
Topics: Adrenergic alpha-Antagonists; Adult; Double-Blind Method; Eye; Eyelids; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Pupil; Quinazolines | 1991 |
5 other study(ies) available for quinazolines and eye
| Article | Year |
|---|---|
Ocular pharmacokinetic/ pharmacodynamic modeling for bunazosin after instillation into rabbits.
Topics: Adrenergic alpha-Antagonists; Algorithms; Animals; Aqueous Humor; Eye; Injections; Intraocular Pressure; Male; Models, Biological; Quinazolines; Rabbits; Tears | 2004 |
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Diarrhea; Drug Interactions; ErbB Receptors; Exanthema; Eye; Female; Gefitinib; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Male; Patient Education as Topic; Quinazolines; Radiography | 2005 |
Drosophila-based in vivo assay for the validation of inhibitors of the epidermal growth factor receptor/Ras pathway.
Topics: Animals; Antineoplastic Agents; Biological Assay; Catalytic Domain; Computer Simulation; Drosophila melanogaster; ErbB Receptors; Erlotinib Hydrochloride; Eye; Gefitinib; Gene Expression Regulation; Models, Molecular; Protein Conformation; Protein Structure, Tertiary; Quinazolines; ras Proteins; Wings, Animal | 2008 |
Modeling glioma growth and invasion in Drosophila melanogaster.
Topics: Animals; Brain Neoplasms; Drosophila melanogaster; ErbB Receptors; Eye; Gefitinib; Glioma; Humans; Immunoenzyme Techniques; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured | 2009 |
Acid-sensing ion channels detect moderate acidifications to induce ocular pain.
Topics: Acid Sensing Ion Channel Blockers; Acid Sensing Ion Channels; Acids; Action Potentials; Amiloride; Animals; Blinking; Cnidarian Venoms; Cornea; Disease Models, Animal; Dry Eye Syndromes; Eye; Guanidines; Guinea Pigs; Hydrogen-Ion Concentration; Male; Nerve Fibers; Ocular Motility Disorders; Ovalbumin; Pain; Patch-Clamp Techniques; Quinazolines; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Sensory Receptor Cells; Statistics, Nonparametric | 2015 |